Data Horizon Co., Ltd. (JP:3628)
:3628
Want to see JP:3628 full AI Analyst Report?
Top Page
Data Horizon Co., Ltd.
(3628)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥432.00
▼(-12.73% Downside)
Action:Reiterated
Date:03/24/26
The score is held down primarily by very weak financial performance—large losses, sharply higher leverage, and significant cash burn. Technical indicators are broadly neutral with only mild short-term improvement, while valuation is somewhat supportive due to a low P/E but is not enough to offset the elevated balance-sheet and liquidity risks.
Positive Factors
Strong revenue growth
Sustained ~80% annual top-line growth indicates meaningful market traction and demand for the firm's offerings. Over a multi-month horizon this revenue momentum can fund scale investments, expand customer reach, and provide a base to drive operating leverage if cost control improves.
Negative Factors
Severe leverage
Debt-to-equity near 22x after equity collapse materially increases refinancing and solvency risk. High leverage constrains strategic flexibility, raises interest obligations, and amplifies downside in weaker revenue periods, making capital structure stability a persistent medium-term concern.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained ~80% annual top-line growth indicates meaningful market traction and demand for the firm's offerings. Over a multi-month horizon this revenue momentum can fund scale investments, expand customer reach, and provide a base to drive operating leverage if cost control improves.
Read all positive factors
Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.34B
Dividend YieldN/A
Average Volume (3M)20.75K
Price to Earnings (P/E)8.9
Beta (1Y)0.15
Revenue Growth0.07%
EPS GrowthN/A
CountryJP
Employees374
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-311.54
Shares Outstanding12,711,780
10 Day Avg. Volume32,020
30 Day Avg. Volume20,746
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)26.38
Price to Sales (P/S)1.14
P/FCF Ratio-3.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Data Horizon Co., Ltd. Business Overview & Revenue Model
Company Description
Data Horizon Corporation provides data health support services to insurers in Japan. It develops and provides medical information services, such as health related data and generic drug notification services, as well as a health business support sy...
How the Company Makes Money
null...
Data Horizon Co., Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.14B | 5.14B | 5.01B | 4.41B | 2.99B | 3.33B |
| Gross Profit | 1.32B | 2.07B | 1.90B | 1.18B | 1.44B | 1.90B |
| EBITDA | 82.80M | 82.80M | -148.66M | -1.59M | -136.32M | 475.24M |
| Net Income | -3.95B | -3.95B | -807.18M | -664.86M | -410.80M | 283.92M |
Balance Sheet | ||||||
| Total Assets | 7.79B | 7.79B | 7.90B | 7.44B | 2.26B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 1.22B | 1.22B | 1.42B | 1.08B | 379.98M | 1.06B |
| Total Debt | 4.81B | 4.81B | 2.46B | 1.47B | 400.00M | 2.66M |
| Total Liabilities | 7.57B | 7.57B | 4.68B | 3.42B | 977.21M | 709.94M |
| Stockholders Equity | 221.67M | 221.67M | 3.19B | 3.97B | 1.26B | 1.54B |
Cash Flow | ||||||
| Free Cash Flow | -154.63M | -1.89B | 64.81M | -253.54M | -747.41M | 232.91M |
| Operating Cash Flow | -145.58M | -1.88B | 120.13M | -198.37M | -442.98M | 395.94M |
| Investing Cash Flow | -177.67M | -673.71M | -789.14M | -3.51B | -572.80M | -391.51M |
| Financing Cash Flow | 410.07M | 2.35B | 1.02B | 4.41B | 331.20M | -56.21M |
Data Horizon Co., Ltd. Technical Analysis
Negative
495.00
Price Trends
499.66
Negative
505.38
Negative
538.58
Negative
Market Momentum
-3.81
Positive
46.06
Neutral
23.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Negative. The current price of 495 is below the 20-day moving average (MA) of 501.45, below the 50-day MA of 499.66, and below the 200-day MA of 538.58, indicating a bearish trend. The MACD of -3.81 indicates Positive momentum. The RSI at 46.06 is Neutral, neither overbought nor oversold. The STOCH value of 23.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3628.
Data Horizon Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥920.15B | 36.11 | 12.15% | 1.01% | 23.33% | 21.65% | |
60 Neutral | ¥175.90B | 31.32 | ― | 0.43% | 20.95% | 13.39% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥71.00B | -232.45 | 5.76% | ― | 23.30% | -56.05% | |
49 Neutral | ¥7.34B | 8.91 | ― | ― | 0.07% | ― | |
44 Neutral | ¥2.41B | -4.65 | ― | ― | 18.86% | 38.80% |
* Healthcare Sector Average
JP:3628
Data Horizon Co., Ltd.
581.00
97.00
20.04%
JP:2413
M3
1,355.00
-569.80
-29.60%
JP:4480
Medley
2,169.00
-1,031.00
-32.22%
JP:4438
Welby Inc.
286.00
-63.00
-18.05%
JP:4483
JMDC Inc.
2,688.00
-438.79
-14.03%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.